JPWO2022177032A1 - - Google Patents
Info
- Publication number
- JPWO2022177032A1 JPWO2022177032A1 JP2023500979A JP2023500979A JPWO2022177032A1 JP WO2022177032 A1 JPWO2022177032 A1 JP WO2022177032A1 JP 2023500979 A JP2023500979 A JP 2023500979A JP 2023500979 A JP2023500979 A JP 2023500979A JP WO2022177032 A1 JPWO2022177032 A1 JP WO2022177032A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021024794 | 2021-02-19 | ||
| JP2021024794 | 2021-02-19 | ||
| PCT/JP2022/008103 WO2022177032A1 (ja) | 2021-02-19 | 2022-02-18 | 骨疾患治療用医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022177032A1 true JPWO2022177032A1 (https=) | 2022-08-25 |
| JP7636032B2 JP7636032B2 (ja) | 2025-02-26 |
Family
ID=82930724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023500979A Active JP7636032B2 (ja) | 2021-02-19 | 2022-02-18 | 骨疾患治療用医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240316109A1 (https=) |
| JP (1) | JP7636032B2 (https=) |
| KR (1) | KR20230133892A (https=) |
| AU (1) | AU2022222868B2 (https=) |
| CA (1) | CA3211195A1 (https=) |
| TW (1) | TWI859508B (https=) |
| WO (1) | WO2022177032A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6363950U (https=) | 1986-06-17 | 1988-04-27 | ||
| JP6463029B2 (ja) * | 2013-08-02 | 2019-01-30 | 有未 伊谷 | ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法 |
| WO2016017795A1 (ja) | 2014-08-01 | 2016-02-04 | 有未 伊谷 | ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体 |
| WO2021144995A1 (ja) * | 2020-01-16 | 2021-07-22 | ＰｕＲＥＣ株式会社 | 高純度間葉系幹細胞 |
-
2022
- 2022-02-18 WO PCT/JP2022/008103 patent/WO2022177032A1/ja not_active Ceased
- 2022-02-18 CA CA3211195A patent/CA3211195A1/en active Pending
- 2022-02-18 JP JP2023500979A patent/JP7636032B2/ja active Active
- 2022-02-18 KR KR1020237028336A patent/KR20230133892A/ko active Pending
- 2022-02-18 US US18/277,618 patent/US20240316109A1/en active Pending
- 2022-02-18 TW TW111105929A patent/TWI859508B/zh active
- 2022-02-18 AU AU2022222868A patent/AU2022222868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230133892A (ko) | 2023-09-19 |
| JP7636032B2 (ja) | 2025-02-26 |
| AU2022222868A1 (en) | 2023-09-07 |
| CA3211195A1 (en) | 2022-08-25 |
| US20240316109A1 (en) | 2024-09-26 |
| WO2022177032A1 (ja) | 2022-08-25 |
| TWI859508B (zh) | 2024-10-21 |
| TW202302123A (zh) | 2023-01-16 |
| AU2022222868B2 (en) | 2026-03-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230525 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20230525 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20230531 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230613 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240423 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240621 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240805 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241126 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250115 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250128 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250205 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7636032 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |